MRI Phenotyping of Early BPD and Prediction of Outcomes

早期 BPD 的 MRI 表型和结果预测

基本信息

  • 批准号:
    10133131
  • 负责人:
  • 金额:
    $ 75.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Bronchopulmonary Dysplasia (BPD) is a chronic disease of prematurity that is increasing in prevalence, is responsible for the majority of neonatal intensive care unit (NICU) admissions across the nation (more than $13B/year in the US), and has high mortality and morbidity. Children with BPD have decreased pulmonary function, increased incidence of pulmonary vascular disease, and lifelong respiratory illnesses including asthma and COPD, with no clear link between initial diagnosis and outcomes. Currently, BPD is defined in terms of supplementary oxygen requirement, but this simplistic definition fails to account for the multifactorial complexity of the disease and its progression. Multiple groups have attempted to define BPD based on functional and physiologic information, but these definitions fail to identify those premature infants who develop BPD or how disease will progress. One of the only established outcomes predictors for BPD is pulmonary arterial hypertension (PAH), but the diagnosis of PAH itself is ambiguous and often delayed, because echocardiography can be inaccurate in these hyperinflated patients. The lack of a clinically prognostic definition of BPD severely limits the ability to predict outcomes or evaluate interventions designed to improve short and long term outcomes. To address this unmet need to assess cardio-respiratory pathology, our team pioneered the use of MRI in the NICU to quantify cardiac, pulmonary and airway abnormalities in prematurely-born neonates. Our ultra-short- echo (UTE) techniques yield 3D images at resolutions similar to CT, provide functional information unavailable from CT, require no ionizing radiation or contrast injection, and can be performed on free-breathing neonates without sedation. Further, this MRI provides structural information about the lung parenchyma and vasculature and dynamic physiologic information from the heart and airways that has never before been available in neonates. Based on strong preliminary data and our demonstrated ability to perform clinically relevant cardiopulmonary MRI in neonates, we will define BPD phenotypes derived from structural and functional abnormalities prevalent in patients. In doing so, we will determine for the first time how specific structure-function abnormalities correspond to regional pathophysiology and patient outcomes in BPD. Our overall goal is to characterize the early sequelae of premature birth via MRI phenotyping, determine the timecourse of disease via longitudinal MRI, predict respiratory outcomes at or near NICU discharge, and relate early clinical care and image phenotyping to 1- and 2-year respiratory outcomes. This proposal draws upon strong preliminary data and multidisciplinary clinical and research programs to establish the first image-derived phenotypes of BPD, in the stage of life when the disease forms and changes rapidly. The impact of the research is high and has strong potential for translation—affecting our understanding and definition of disease and its formation, with likely impact on future respiratory support, critical care, and outcomes.
项目总结 支气管肺发育不良(BPD)是一种慢性早产儿疾病,患病率正在上升,是 负责全国大部分新生儿重症监护病房(NICU)的入院工作(超过 在美国为130亿美元/年),并且死亡率和发病率很高。患有BPD的儿童肺活量减少 功能,肺血管疾病的发病率增加,以及包括哮喘在内的终身呼吸系统疾病 和慢性阻塞性肺病,在初始诊断和结果之间没有明确的联系。目前,BPD定义为 补充氧量,但这个简单的定义没有考虑到多因素的复杂性 疾病及其发展的最新进展。多个小组已尝试根据功能和 生理信息,但这些定义未能识别出哪些早产儿或如何发展为BPD。 疾病会继续发展。唯一确定的预测BPD预后的指标之一是肺动脉。 高血压(PAH),但PAH本身的诊断是模棱两可的,而且经常被延误,因为超声心动图 在这些过度膨胀的患者身上可能是不准确的。严重缺乏BPD的临床预后定义 限制预测结果或评估旨在改善短期和长期结果的干预措施的能力。 为了解决这一未得到满足的评估心肺病理的需求,我们的团队率先在 NICU用于量化早产儿的心脏、肺和呼吸道异常。我们的超短裤- 回波(UTE)技术以类似于CT的分辨率生成3D图像,提供不可用的功能信息 CT不需要电离辐射或造影剂注射,可以在自由呼吸的新生儿身上进行 没有镇静剂。此外,MRI还提供了有关肺实质和血管系统的结构信息 以及来自心脏和呼吸道的动态生理信息,这是以前从未在 新生儿。基于强大的初步数据和我们证明的临床相关能力 在新生儿的心肺MRI中,我们将根据结构和功能来定义BPD的表型 患者中普遍存在的异常现象。在这样做的过程中,我们将首次确定具体的结构-功能 BPD的异常与局部病理生理学和患者预后相对应。 我们的总体目标是通过MRI表型来表征早产的早期后遗症,确定 通过纵向MRI预测NICU出院时或出院附近的呼吸结果,并与 早期临床护理和影像表型对1年和2年后的呼吸结果的影响。这项建议借鉴了 强大的初步数据和多学科的临床和研究计划,建立了第一个图像派生的 BPD的表型,在疾病形成和迅速变化的生命阶段。研究的影响 是高的,并具有很强的翻译潜力-影响我们对疾病及其 形成,可能对未来的呼吸支持、危重护理和预后产生影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON C WOODS其他文献

JASON C WOODS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON C WOODS', 18)}}的其他基金

MRI Phenotyping of Early BPD and Prediction of Outcomes
早期 BPD 的 MRI 表型和结果预测
  • 批准号:
    9902529
  • 财政年份:
    2019
  • 资助金额:
    $ 75.76万
  • 项目类别:
MRI Phenotyping of Early BPD and Prediction of Outcomes
早期 BPD 的 MRI 表型和结果预测
  • 批准号:
    10383655
  • 财政年份:
    2019
  • 资助金额:
    $ 75.76万
  • 项目类别:
MARC U-STAR Program at Washington University in St. Louis
圣路易斯华盛顿大学 MARC U-STAR 项目
  • 批准号:
    7630652
  • 财政年份:
    2009
  • 资助金额:
    $ 75.76万
  • 项目类别:
MARC U-STAR Program at Washington University in St. Louis
圣路易斯华盛顿大学 MARC U-STAR 项目
  • 批准号:
    7849945
  • 财政年份:
    2009
  • 资助金额:
    $ 75.76万
  • 项目类别:
MARC U-STAR Program at Washington University in St. Louis
圣路易斯华盛顿大学 MARC U-STAR 项目
  • 批准号:
    8080867
  • 财政年份:
    2009
  • 资助金额:
    $ 75.76万
  • 项目类别:
EVALUATION OF ENDOBRONCHIAL INTERVENTIONS FOR COPD VIA CT AND 3HE MRI
通过 CT 和 3HE MRI 评估 COPD 的支气管内干预措施
  • 批准号:
    8691020
  • 财政年份:
    2008
  • 资助金额:
    $ 75.76万
  • 项目类别:
EVALUATION OF ENDOBRONCHIAL INTERVENTIONS FOR COPD VIA CT AND 3HE MRI
通过 CT 和 3HE MRI 评估 COPD 的支气管内干预措施
  • 批准号:
    8128685
  • 财政年份:
    2008
  • 资助金额:
    $ 75.76万
  • 项目类别:
EVALUATION OF ENDOBRONCHIAL INTERVENTIONS FOR COPD VIA CT AND 3HE MRI
通过 CT 和 3HE MRI 评估 COPD 的支气管内干预措施
  • 批准号:
    7898928
  • 财政年份:
    2008
  • 资助金额:
    $ 75.76万
  • 项目类别:
EVALUATION OF ENDOBRONCHIAL INTERVENTIONS FOR COPD VIA CT AND 3HE MRI
通过 CT 和 3HE MRI 评估 COPD 的支气管内干预措施
  • 批准号:
    7677278
  • 财政年份:
    2008
  • 资助金额:
    $ 75.76万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了